Loading...

TNGX TANGO THERAPEUTICS INC Earnings Reports 8-K Filing

TNG

TNGX

TANGO THERAPEUTICS INC

(TNGX)

2025 8-K

Board Resignations

Management Change

Leadership Changes

Earnings Report

Leadership Changes

Director Appointment

Stock Sales Update

Financial Results Update

Stock Offering Announcement

Financial Update

Management Change

Financial Statements

Increase in authorized shares

Financial Statements

New Partnership

Funding Increase

Clinical Trial Update

Filing with Quantitative Data

Financial Update

Filing with Quantitative Data

Private Placement

Quantitative Data

Filing with Quantitative Data

External Links:

On October 23, 2025, Tango Therapeutics, Inc. reported a preliminary cash and securities estimate of $152.8 million as of September 30, 2025, alongside a clinical update on its ongoing trials.

AI Assistant

TANGO THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.